Back

Restoring cardioprotection via S1P-Enriched HDL in coronary artery disease

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic crosstalk and microbiome Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marcel Benkhoff

University Hospital Duesseldorf, Duesseldorf (Germany)

5 More presentations in this session

Presentation thumbnail
Live probiotic supplementation mitigates caffeine-induced autonomic imbalance and nocturnal sympathetic predominance: implications for cardiovascular risk
Doctor W. Lin (Taichung, TW)
Abstract Slides
Presentation thumbnail
Intercellular cross-talk induced by dietary nitrate enhances contractile performance in cardiomyocytes after ischemic injury independently of Ca²⁺ homeostasis alterations
Professor L. Lund (Stockholm, SE)
Abstract Slides
Presentation thumbnail
BMP-7 treatment ameliorates ponatinib-induced inflammatory mechanisms and cardiac dysfunction
Professor D. Singla (Orlando, US)
Abstract Slides
Presentation thumbnail
Cardiovascular–kidney–metabolic syndrome drives coronary microvascular dysfunction in postmenopausal minipigs
Doctor O. Sorop (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Neuroimmune mechanisms recruited by salt-dependent hypertensive stimuli shape splenic and gut components to influence cardiac function
Doctor A. Migliaccio (Pozzilli, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiometabolic crosstalk and microbiome

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
S1P content as a characteristic of the cardioprotective properties of HDL in coronary heart disease and diabetes mellitus
26 August 2023
thumbnail
Congress Presentation
Small dense low-density lipoprotein cholesterol predicts long-term recurrence of coronary artery disease in patients without metabolic dyslipidemia
25 April 2026
thumbnail
Congress Presentation
Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study
1 September 2019
thumbnail
Congress Presentation
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources